Hashish VI1: Conversion of (-)-Δ 1(6)-Tetrahydrocannabinol to (-)-Δ 1(7)-Tetrahydrocannabinol. Stability of (-)-Δ 1 and (-)-Δ 1(6)-Tetrahydrocannabinols

Zusammenfassung Die Synthese von (—)-¹⁽⁷⁾-Tetrahydrocannabinol (THC) auf (—)-¹⁽⁶⁾ wird beschrieben. Das Hauptprodukt der oxidativen Zerstörung von (—)-¹-THC ist Cannabinol. Beschleunigte Versuche der Luftoxidation von (—)-¹-THC und (—)-¹⁽⁶⁾-THC haben gezeigt, dass das letztere beständiger ist. Dieser Unterschied kann mit der Reaktivität des C₃-benzylisch-allylischen Wasserstoffes in (—)-¹-THC erklärt werden.     

Antihypertensive agents III. Synthesis and antihypertensive activity of 3-[4-(p-fluoro-phenyl)-1,2,3,6-tetrahydro-1-pyridyl]-1-[1-(2-hydroxyethyl)-5-methyl-4-pyrazolyl]-1-propanone

Zusammenfassung 3-[4-(p-Fluorphenyl)-1,2,3,6-te-trahydro-1-pyridyl]-1-[1-(2-hydroxyaethyl)-5-methyl-4-pyrazolyl]-1-propanon (I, CIBA 4416/B-Go) senkt bei normotonischen und hypertonischen Tieren den Blutdruck. Die Drucksenkung kann hauptsächlich auf die periphere Vasodilatation sowie auf die Vasomotorenzentren bezogen werden. Ausserdem wirkt CIBA 4416/B-Go adrenolytisch.

---

Previous paper:V. P. Arya, R. S. Grewal, C. L. Kaul, S. P. Ghate, D. V. Mehta andT. George, J. Pharm. Sci.58, 432 (1969).Contribution No. 243 from CIBA Research Centre.     

1-(5-Methyl-1-phenyl-4-pyrazolyl)-3-[4-(o-tolyl)-piperazinyl]-1-propanone,a new synthetic antihypertensive agent

Zusammenfassung 1-(5-Methyl-1-phenyl-4-pyrazolyl)-3-[4-(o-tolyl)-piperazinyl]-1-propanone (I; CIBA 1002-Go), senkt an normotonischen und hypertonischen Tieren den Blutdruck. Die Drucksenkung kann auf eine periphere Vasodilatation und eine Hemmung hypothalamischer oder medullärer Vasomotorenzentren bezogen werden. Ausserdem wirkt CIBA 1002-Go adrenolytisch.

---

---

Hydrochloride = CIBA 1002-Go.     

Interaction of chloramphenicol and 181-1181-1181-1in barbital-anesthetized mice

Résumé L'augmentation de l'anesthésie produite par le barbital chez la souris traitée au ¹-tétrahydrocannabinol ( ¹-THC) à 10 ou 20 mg/kg par voie i.p. est accentuée d'une manière significative par le traitement préalable au chloramphénicol (CHPC) à 100 mg/kg, mais non pas par 50 mg/kg de ce composé injecté par voie i.p. Le CHPC seul n'a aucun effet. Le CHPC étant un inhibiteur des systèmes enzymatiques des microsomes hépatiques, on en a conclu que l'effet du ¹-THC sur le prolongement de la durée du sommeil au barbital est dû au composé parent plutôt qu'à l'un des produits de transformation biologique.     

Effect of 723-1723-1723-1on ethanol withdrawal in mice

Summary ⁹ (10 mg/kg, i.p.) administered to mice immediately after withdrawal from a 3-day exposure to ethanol vapor was found to intensify withdrawal reactions. No effect was seen when ⁹ was administered chronically during the exposure to ethanol.     

The efficacy of a novel compound, (E)-1-(4′-bromo-4-biphenylyl)-1-(4-chlorophenyl)-3-dimethylaminoprop-1-ene againstTrypanosoma cruzi in mice

Summary The biological properties of a novel compound 353C with high activity againstTrypanosoma cruzi, are described. The compound was about 10 times and 20 times more effective than either benznidazole or nifurtimox respectively, in producing radical cure in mice. 353C had a long half-life and showed anti-trypanosomal properties when given to mice at weekly intervals.     

Mechanisms of increased 470-1470-1470-1production in hepatic injury

Summary The increased production of ₁ in injured liver is primarily associated with hepatic injury and not with liver cell regeneration.     

(-)-(R)-1-O-Geranylgeranylglycerol from the brown alga Dilophus fasciola

Summary A novel ether lipid, (-)-(R)-1-O-geranylgeranylglycerol (1), has been isolated from the brown alga Dilophus fasciola and its structure proved by spectroscopic methods and chemical degradation.This work was supported by CNR, Rome, Italy.     

Pharmacological studies of a new analgesic,dl-erythro-1-phenyl-2-(o-chlorophenyl)-2-[4-(p-methoxybenzyl)-1-piperazinyl] ethanol dihydrochloride,in experimental animals

Summary dl-Erythro-1-phenyl-2-(o-chlorophenyl)-2-[4-(p-methoxybenzyl)-1-piperazinyl] ethanol dihydrochloride showed orally a definite analgesic activity, without producing the significant morphine-like physical dependence liability, and its analgesic potency was about a half that of codeine and far superior to aminopyrine in experimental animals.     

Tolerance to,and symmetrical cross-tolerance between,cannabionol and 295-1295-1295-1

Summary Tolerance to, and symmetrical cross-tolerance between, cannabinol and ⁹-tetrahydrocannabinnol (THC) occurs in rabbits which uniquely exhibit behavioral convulsions with THC.This research was supported by funds (grant No.DA01448) and cannabinoids from the National Institute on Drug Abuse.     

A one-step synthesis of (-)-Δ1-Tetrahydrocannabinol from chrysanthenol

Zusammenfassung Eine Einschritt-Synthese von (—)-Tetrahydrocannabinol¹ (THC) ausgehend von Chrysanthenol mit möglichen biogenetischen Folgerungen wird beschrieben.     

Pharmacological studies of a new analgesic, dl-erythro-1-phenyl-2-(o-chlorophenyl)-2-[4-(p-methoxybenzyl)-1-piperazinyl] ethanol dihydrochloride, in experimental animals.

dl-Erythro-1-phenyl-2-(o-chlorophenyl)-2-[4-(p-methoxybenzyl)-1-piperazinyl] ethanol dihydrochloride showed orally a definite analgesic activity, without producing the significant morphine-like physical dependence liability, and its analgesic potency was about a half that of codeine and far superior to aminopyrine in experimental animals.     

Effect of imazalil (1-(2-(2,4-dichlorophenyl)-2-(2-propenyloxy) ethyl)-1H-imidazole) on biosynthesis of ergosterol in Penicillium expansum Link]

Imazalil is a new fungicide effective against Penicillium molds on fruits after harvest. This compound inhibits ergosterol biosynthesis in mycelia of Penicillium expansum. The accumulation of 24--methylenedithydrolanosterol, obtusifoliol and 14 alpha-methyl-delta 8, 24(28)-ergostadienol in treated fungi suggests that imazalil blocks sterol C--14 demethylation.     

The duration of action of the synthetic pentacosapeptideD-Serine1-norleucine4-valinamide25-β-1-25-corticotrophin (DW-75) in man

Résumé L'activité de la corticotrophine porcine a une durée plus longue que celle du DW-75, quand on l'administre en quantités égales, basées sur un test biologique. Le DW-75 a une durée d'activité plus longue par injection intraveneuse que par injection intramusculaire. Une quantité nanagramme du DW-75 a la même action stimulante adrénocorticale que le synacthène.